Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Interest Expenses (2016 - 2022)

Niagen Bioscience (NAGE) has disclosed Interest Expenses for 13 consecutive years, with $5000.0 as the latest value for Q3 2022.

  • Quarterly Interest Expenses fell 66.67% to $5000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $5000.0 through Jun 2023, down 88.1% year-over-year, with the annual reading at $55000.0 for FY2021, 22.54% down from the prior year.
  • Interest Expenses for Q3 2022 was $5000.0 at Niagen Bioscience, down from $10000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $575000.0 in Q2 2019, with the low at $5000.0 in Q3 2022.
  • Average Interest Expenses over 5 years is $55133.3, with a median of $15000.0 recorded in 2021.
  • The sharpest move saw Interest Expenses surged 1097.92% in 2019, then plummeted 95.83% in 2020.
  • Over 5 years, Interest Expenses stood at $14000.0 in 2018, then surged by 4007.14% to $575000.0 in 2019, then tumbled by 97.22% to $16000.0 in 2020, then tumbled by 43.75% to $9000.0 in 2021, then crashed by 44.44% to $5000.0 in 2022.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $5000.0, $10000.0, and $8000.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.